176 related articles for article (PubMed ID: 23856826)
41. [Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
Zengerling F; Schrader AJ; Schrader M; Jentzmik F
Aktuelle Urol; 2012 Jan; 43(1):49-54. PubMed ID: 21769763
[TBL] [Abstract][Full Text] [Related]
42. Hürthle Cell Thyroid Adenoma Showing Avid Uptake on 18F-PSMA-1007 PET/CT.
Tang K; Wang Z; Lin J; Zheng X
Clin Nucl Med; 2020 Mar; 45(3):223-224. PubMed ID: 31876816
[TBL] [Abstract][Full Text] [Related]
43. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
[TBL] [Abstract][Full Text] [Related]
44. [Focus: Prostate cancer and PET-choline].
Brenot-Rossi I
Prog Urol; 2014 Jan; 24(1):3-8. PubMed ID: 24365622
[TBL] [Abstract][Full Text] [Related]
45. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
Poulsen MH; Petersen H; Høilund-Carlsen PF; Jakobsen JS; Gerke O; Karstoft J; Steffansen SI; Walter S
BJU Int; 2014 Dec; 114(6):818-23. PubMed ID: 24314065
[TBL] [Abstract][Full Text] [Related]
46. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
47. Asymptomatic metastasis to cricoid from prostate carcinoma: an incidental finding detected on 18F-choline PET/CT.
Ng SJ; Sinha AK; Loi HY; Khor LK
Jpn J Radiol; 2015 May; 33(5):298-301. PubMed ID: 25820451
[TBL] [Abstract][Full Text] [Related]
48. Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.
Rager O; Baskin A; Amzalag G; Buchegger F; Miralbell R; Ratib O; Zilli T; Garibotto V
Nuklearmedizin; 2015; 54(5):211-6. PubMed ID: 26213186
[TBL] [Abstract][Full Text] [Related]
49. Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer.
Pinaquy JB; De Clermont-Galleran H; Pasticier G; Rigou G; Alberti N; Hindie E; Mokrane Y; Fernandez P
Prostate; 2015 Feb; 75(3):323-31. PubMed ID: 25393215
[TBL] [Abstract][Full Text] [Related]
50. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
[TBL] [Abstract][Full Text] [Related]
51. 18F-fluorocholine uptake in a case of adrenal incidentaloma: possible diagnostic pitfall or potential tool for adrenocortical tumors characterization?
Imperiale A; Cabral JF; Rust E; Flores-Turk G; Renard C; Hubele F; Detour J; Lang H; Gangi A; Namer IJ
Clin Nucl Med; 2013 Feb; 38(2):e83-4. PubMed ID: 23334144
[TBL] [Abstract][Full Text] [Related]
52. Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients.
Cegla P; Scibisz-Dziedzic K; Witkowska K; Kubiak A; Wierzchoslawska E; Kycler W; Chrapko B; Czepczyński R
Nucl Med Rev Cent East Eur; 2022; 25(1):25-30. PubMed ID: 35137934
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
[TBL] [Abstract][Full Text] [Related]
54. Thyroid Incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT Revealing a Medullary Thyroid Carcinoma.
Ciappuccini R; Edet-Sanson A; Saguet-Rysanek V; Gauthé M; Bardet S
Clin Nucl Med; 2019 Aug; 44(8):663-665. PubMed ID: 31274618
[TBL] [Abstract][Full Text] [Related]
55. Fluorocholine PET/CT in patients with prostate cancer: initial experience.
Schmid DT; John H; Zweifel R; Cservenyak T; Westera G; Goerres GW; von Schulthess GK; Hany TF
Radiology; 2005 May; 235(2):623-8. PubMed ID: 15858102
[TBL] [Abstract][Full Text] [Related]
56. [Thymic uptake of 18FFDG following radioiodine ablation therapy].
Albalá González MD; Martínez Gimeno E; Cárdenas Negro C; Allende Riera A; Cabello García D; De Sequera Rahola M; Uña Gorospe JA
Rev Esp Med Nucl; 2011; 30(5):314-6. PubMed ID: 21342725
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic accuracy of (18) F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma.
Bieze M; Klümpen HJ; Verheij J; Beuers U; Phoa SS; van Gulik TM; Bennink RJ
Hepatology; 2014 Mar; 59(3):996-1006. PubMed ID: 24123111
[TBL] [Abstract][Full Text] [Related]
58. Role of 18F-choline PET/CT in biochemically relapsed prostate cancer after radical prostatectomy: correlation with trigger PSA, PSA velocity, PSA doubling time, and metastatic distribution.
Marzola MC; Chondrogiannis S; Ferretti A; Grassetto G; Rampin L; Massaro A; Castellucci P; Picchio M; Al-Nahhas A; Colletti PM; Marcolongo A; Rubello D
Clin Nucl Med; 2013 Jan; 38(1):e26-32. PubMed ID: 23242060
[TBL] [Abstract][Full Text] [Related]
59. Intense 18F-choline uptake after minor head injury: misleading PET/CT result in a patient with biochemical relapse of prostate adenocarcinoma.
Leyendecker P; Imperiale A; Matern JF; Noël G; Namer IJ
Clin Nucl Med; 2014 Nov; 39(11):1012-3. PubMed ID: 24999703
[TBL] [Abstract][Full Text] [Related]
60. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]